Postmenopausal osteoporosis in women is a consequence of decreasing oestrogen levels and is associated with rapid bone loss (“high-turnover osteoporosis”). Long-term therapy concepts are required to achieve sustainable effects – if osteoporosis medication is discontinued without follow-up treatment, the osteoprotective effect is lost and there is a risk of renewed bone density loss. Sequential treatment strategies are therefore crucial to prevent rebound effects.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Abdominal pain – Hernias
- "Survey of Health, Ageing and Retirement in Europe" (SHARE)
Analysis of polypharmacy in ≥65-year-olds
- New perspectives for clinics and research
Ageing, cellular senescence and Parkinson’s disease
- From early intervention to individualization
The new guidelines at a glance
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- Focus on prevention
Colorectal cancer screening – an update
- COPD therapy
Drug therapy – Update 2025
- From symptom to diagnosis
 
						
						 
					 
			 
						 
						 
																	 
																	 
																	 
																	 
																	 
																	 
																	